Otsuka Holdings Co (STU:OS1) Moat Score: 7/10 (As of Jul. 01, 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
82 GF Score
Price €58.50
GF Value €45.20
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Otsuka Holdings Co Moat Score?

Otsuka Holdings Co STU:OS1 -1.68% 82 Moat Score is 7 as of Jul. 01, 2026. GuruFocus rates STU:OS1 with a GF Score™ of 82/100 and a GF Value™ of €45.20 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,031 Drug Manufacturers companies, Otsuka Holdings Co ranks better than 98.64% on this metric.

Otsuka Holdings Co has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Otsuka Holdings Co has Wide Moat: Otsuka Holdings has a strong market position in pharmaceuticals with valuable patents and a robust R&D pipeline. Its brand strength and economies of scale provide durable cost advantages, while regulatory barriers enhance its competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Otsuka Holdings Co might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Otsuka Holdings Co  (STU:OS1) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Otsuka Holdings Co Moat Score Related Terms

STU:OS1 vs LLY, JNJ, ABBV: Moat Score Comparison

For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otsuka Holdings Co Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Otsuka Holdings Co's Moat Score falls into.


STU:OS1
82GF Score
Otsuka Holdings Co Ltd STU:OS1
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Otsuka Holdings Co (STU:OS1) has a Moat Score of 7 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Otsuka Holdings Co ranks #14 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 1.4%.
Is Otsuka Holdings Co's Moat Score too high?
Otsuka Holdings Co's current Moat Score is 7. Based on the distribution chart, Otsuka Holdings Co ranks #14 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Otsuka Holdings Co has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Moat Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Otsuka Holdings Co ranks #14 out of 1031 companies for Moat Score. This places Otsuka Holdings Co in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Otsuka Holdings Co's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Modestly Overvalued. The stock's GF Value™ is €45.20, compared to a current price of €58.50 — trading 29.4% above its estimated fair value. The current Moat Score is 7. Otsuka Holdings Co's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current Moat Score is 7 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €58.50 is trading 29.4% above its estimated GF Value™ of €45.20. GuruFocus considers Otsuka Holdings Co to be Modestly Overvalued.

Key valuation signals for STU:OS1:

  • Moat Score: 7
  • GF Value™: €45.20 vs. price of €58.50 (29.4% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
82GF Score

Get the complete analysis for STU:OS1

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€58.50
Price
€45.20
GF Value